Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 08-Apr-24 5:22 PM View:  | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 08-Apr-24 | Payment of Exercise | 4,075 | $17.90 | $72,942.50 | (2%) 176.88K to 172.81K | |
| 08-Apr-24 5:22 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 08-Apr-24 | Option Exercise | 9,992 | -- | -- | 6% 166.89K to 176.88K | |
| 03-Apr-24 5:22 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 01-Apr-24 | Payment of Exercise | 1,903 | $19.70 | $37,489.10 | (1%) 168.79K to 166.89K | |
| 03-Apr-24 5:22 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 01-Apr-24 | Option Exercise | 6,482 | -- | -- | 4% 162.31K to 168.79K | |
| 11-Mar-24 7:05 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 07-Mar-24 | Private Sale (Planned) | 65,012 | $21.02 | $1,366,550.00 | (29%) 227.32K to 162.31K | |
| 06-Mar-24 10:00 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 06-Mar-24 | Sale (Planned) | 5,582 | $21.00 | $117,222.00 | (2%) 232.91K to 227.32K | |
| 06-Mar-24 10:00 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 04-Mar-24 | Private Sale (Planned) | 12,742 | $21.49 | $273,834.00 | (5%) 245.65K to 232.91K | |
| 06-Sep-23 7:06 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 02-Sep-23 | Payment of Exercise | 2,187 | $17.76 | $38,841.10 | (< 1%) 247.83K to 245.65K | |
| 06-Sep-23 7:06 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 02-Sep-23 | Option Exercise | 6,569 | -- | -- | 3% 241.26K to 247.83K | |
| 06-Sep-23 7:06 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 01-Sep-23 | Payment of Exercise | 4,432 | $17.76 | $78,712.30 | (2%) 245.7K to 241.26K | |
| 06-Sep-23 7:06 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 01-Sep-23 | Option Exercise | 9,992 | -- | -- | 4% 235.71K to 245.7K | |
| 11-Apr-23 5:05 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 10-Apr-23 | Payment of Exercise | 2,933 | $10.71 | $31,412.40 | (1%) 238.64K to 235.71K | |
| 11-Apr-23 5:05 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 10-Apr-23 | Option Exercise | 9,992 | -- | -- | 4% 228.65K to 238.64K | |
| 20-Mar-23 5:16 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 20-Mar-23 | Payment of Exercise | 3,523 | $11.12 | $39,175.80 | (2%) 232.17K to 228.65K | |
| 20-Mar-23 5:16 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 20-Mar-23 | Option Exercise | 12,002 | -- | -- | 5% 220.17K to 232.17K | |
| 20-Mar-23 5:16 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 16-Mar-23 | Payment of Exercise | 1,929 | $11.46 | $22,106.30 | (< 1%) 222.1K to 220.17K | |
| 20-Mar-23 5:16 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 16-Mar-23 | Option Exercise | 6,569 | -- | -- | 3% 215.53K to 222.1K | |
| 06-Sep-22 4:11 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 02-Sep-22 | Payment of Exercise | 1,929 | $11.44 | $22,067.80 | (< 1%) 217.46K to 215.53K | |
| 06-Sep-22 4:11 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 02-Sep-22 | Option Exercise | 6,569 | -- | -- | 3% 210.89K to 217.46K | |
| 23-Mar-22 4:30 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 21-Mar-22 | Payment of Exercise | 5,446 | $10.98 | $59,797.10 | (3%) 216.33K to 210.89K | |
| 23-Mar-22 4:30 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 21-Mar-22 | Option Exercise | 18,555 | -- | -- | 9% 197.78K to 216.33K | |
| 18-Mar-22 4:38 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 16-Mar-22 | Payment of Exercise | 1,922 | $10.13 | $19,469.90 | (< 1%) 199.7K to 197.78K | |
| 18-Mar-22 4:38 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 16-Mar-22 | Option Exercise | 6,569 | -- | -- | 3% 193.13K to 199.7K | |
| 10-Feb-21 7:07 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 10-Feb-21 | Option Exercise | 1,600 | $1.59 | $2,544.00 | < 1% 194.27K to 195.87K | |
| 10-Feb-21 7:07 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 10-Feb-21 | Market Sale (Planned) | 1,600 | $23.06 | $36,896.00 | (< 1%) 195.87K to 194.27K | |
| 10-Feb-21 7:07 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 10-Feb-21 | Market Sale (Planned) | 1,137 | $23.07 | $26,230.60 | (< 1%) 194.27K to 193.13K | |
| 10-Feb-21 7:07 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 09-Feb-21 | Option Exercise | 20,401 | $1.59 | $32,437.60 | 9% 217.84K to 238.24K | |
| 10-Feb-21 7:07 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 09-Feb-21 | Market Option Sale (Planned) | 15,873 | $23.04 | $365,714.00 | (7%) 238.24K to 222.37K | |
| 10-Feb-21 7:07 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 09-Feb-21 | Market Sale (Planned) | 4,528 | $23.04 | $104,325.00 | (2%) 222.37K to 217.84K | |
| 10-Feb-21 7:07 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 09-Feb-21 | Market Option Sale (Planned) | 1,600 | $23.08 | $36,928.00 | (< 1%) 217.84K to 216.24K | |
| 10-Feb-21 7:07 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 09-Feb-21 | Market Sale (Planned) | 21,969 | $23.08 | $507,045.00 | (10%) 216.24K to 194.27K | |
| 10-Feb-21 7:07 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 08-Feb-21 | Option Exercise | 4,924 | $1.59 | $7,829.16 | 2% 222.37K to 227.29K | |
| 10-Feb-21 7:07 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 08-Feb-21 | Market Option Sale (Planned) | 4,924 | $23.00 | $113,252.00 | (2%) 227.29K to 222.37K | |
| 10-Feb-21 7:07 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 08-Feb-21 | Market Option Sale (Planned) | 4,528 | $23.00 | $104,144.00 | (2%) 222.37K to 217.84K | |
| 14-Oct-20 5:22 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 12-Oct-20 | Option Exercise | 150,700 | $1.59 | $239,613.00 | 47% 321.69K to 472.39K | |
| 14-Oct-20 5:22 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 12-Oct-20 | Market Option Sale (Planned) | 150,030 | $21.02 | $3,153,630.00 | (32%) 472.39K to 322.37K | |
| 14-Oct-20 5:22 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 12-Oct-20 | Market Sale (Planned) | 670 | $21.02 | $14,083.40 | (< 1%) 322.37K to 321.69K | |
| 14-Oct-20 5:22 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 12-Oct-20 | Market Sale (Planned) | 99,330 | $21.02 | $2,087,920.00 | (31%) 321.69K to 222.37K | |
| 14-Oct-20 5:22 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 09-Oct-20 | Option Exercise | 872 | $1.59 | $1,386.48 | < 1% 322.37K to 323.24K | |
| 14-Oct-20 5:22 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 09-Oct-20 | Market Option Sale (Planned) | 872 | $21.00 | $18,312.00 | (< 1%) 323.24K to 322.37K | |
| 14-Oct-20 5:22 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 09-Oct-20 | Market Option Sale (Planned) | 670 | $21.00 | $14,070.00 | (< 1%) 322.37K to 321.69K | |
| 10-Mar-20 5:33 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 06-Mar-20 | Market Sale (Planned) | 33,115 | $20.00 | $662,300.00 | (9%) 355.48K to 322.37K | |
| 13-Feb-20 10:00 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 07-Aug-19 | Gift | 245,685 | -- | -- | 69% 355.48K to 601.16K | |
| 13-Feb-20 10:00 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 07-Aug-19 | Gift | 245,685 | -- | -- | (41%) 601.16K to 355.48K | |
| 29-May-18 7:20 PM View: | Kiniksa Pharmaceuticals, Ltd. (KNSA) | 29-May-18 | Conversion | 135,889 | -- | -- | 62% 219.59K to 355.48K | |
| 23-Jun-15 10:37 AM View: | Trimeris Inc. (GEVA) | 22-Jun-15 | Disposition | 286 | -- | -- | (< 1%) 73.32K to 73.03K | |
| 23-Jun-15 10:37 AM View: | Trimeris Inc. (GEVA) | 22-Jun-15 | Disposition | 73,031 | -- | -- | (100%) 73.03K to 0 | |
| 09-Jun-15 6:15 PM View: | Trimeris Inc. (GEVA) | 05-Jun-15 | Grant | 72,000 | -- | -- | 5467% 1.32K to 73.32K | |
| 19-Dec-14 5:56 PM View: | Trimeris Inc. (GEVA) | 17-Dec-14 | Option Exercise | 50,000 | $15.28 | $763,972.00 | 4850% 1.03K to 51.03K | |
| 19-Dec-14 5:56 PM View: | Trimeris Inc. (GEVA) | 17-Dec-14 | Market Option Sale (Planned) | 50,000 | $88.85 | $4,442,360.00 | (98%) 51.03K to 1.03K | (165%) |